Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zishen Ningshen Wan is a Traditional Chinese Medicine (TCM) manufactured by Zhongshan Shaxi Chinese Medicine Factory. It is formulated to nourish the kidney yin, supplement the heart, and calm the spirit (Shen). The preparation is primarily indicated for the treatment of insomnia, dizziness, tinnitus, palpitations, and restlessness associated with kidney yin deficiency and the failure of heart and kidney to communicate. As a complex herbal formulation, it typically contains ingredients such as Rehmannia glutinosa, Salvia miltiorrhiza, and Polygala tenuifolia, which work synergistically to restore internal balance and modulate the neuroendocrine system. It is widely utilized in China for managing symptoms of neurasthenia and menopausal syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zishen ningshen wan.